KPIs & Operating Metrics(New)
Growth Metrics

Bausch Health Companies (BHC) Short term Debt (2016 - 2025)

Historic Short term Debt for Bausch Health Companies (BHC) over the last 16 years, with Q3 2025 value amounting to $579.0 million.

  • Bausch Health Companies' Short term Debt rose 2781.46% to $579.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $579.0 million, marking a year-over-year increase of 2781.46%. This contributed to the annual value of $2.7 billion for FY2024, which is 49422.22% up from last year.
  • Latest data reveals that Bausch Health Companies reported Short term Debt of $579.0 million as of Q3 2025, which was up 2781.46% from $879.0 million recorded in Q2 2025.
  • Bausch Health Companies' Short term Debt's 5-year high stood at $2.7 billion during Q4 2024, with a 5-year trough of $150.0 million in Q2 2022.
  • For the 4-year period, Bausch Health Companies' Short term Debt averaged around $623.3 million, with its median value being $451.0 million (2023).
  • Per our database at Business Quant, Bausch Health Companies' Short term Debt soared by 49422.22% in 2024 and then plummeted by 4758.36% in 2025.
  • Bausch Health Companies' Short term Debt (Quarter) stood at $432.0 million in 2022, then grew by 4.17% to $450.0 million in 2023, then skyrocketed by 494.22% to $2.7 billion in 2024, then plummeted by 78.35% to $579.0 million in 2025.
  • Its Short term Debt stands at $579.0 million for Q3 2025, versus $879.0 million for Q2 2025 and $282.0 million for Q1 2025.